The National Prescribing Centre has published a MeReC Bulletin (PDF) that focuses on how to best manage blood glucose in the overall context of preventing both macrovascular and microvascular diabetic complications.
This bulletin uses a case study approach to discuss treatment priorities, optimal blood glucose control and hypoglycaemic drug therapy.
In particular this review discusses the relative advantages and disadvantages of newer hypoglycaemic agents including long-acting insulin analogues, the place for triple therapy and the optimal blood glucose.
Action: Clinicians who treat patients with type 2 diabetes will find this bulletin is a useful review of the management of blood glucose.
|« Dementia care - call to action||Anticholinergic drugs linked to health risks »|